FUSN · Categories · Form 4

FUSN - SEC Form 4 insider transactions

Fusion Pharmaceuticals Inc. (FUSN) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for FUSN

• 691d
  SEC Form 4 filed by Bitetti Teresa Marie

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 691d
  Gannon Steven returned 56,400 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 691d
  Valliant John returned 318,147 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 691d
  SEC Form 4 filed by Cagnoni Pablo J

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 691d
  SEC Form 4 filed by Lee Philina

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 691d
  Rawat Mohit returned 21,699 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 691d
  Crowley John J returned 10,410 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 691d
  SEC Form 4 filed by Meek David D.

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 691d
  SEC Form 4 filed by Bobilev Dmitri

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 691d
  SEC Form 4 filed by Bender Jeremy

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 691d
  SEC Form 4 filed by Duncan Barbara Gayle

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 691d
  Burak Eric returned 38,490 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 691d
  Leamon Christopher P returned 11,957 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 691d
  SEC Form 4 filed by Bergstrom Donald A

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 842d
  Leamon Christopher P was granted 11,957 shares (SEC Form 4)

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 842d
  SEC Form 4 filed by Crowley John J

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 842d
  SEC Form 4 filed by Burak Eric

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 842d
  Rawat Mohit was granted 12,843 shares (SEC Form 4)

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 842d
  SEC Form 4 filed by Bobilev Dmitri

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 842d
  SEC Form 4 filed by Valliant John

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 923d
  SEC Form 4 filed by Meek David D.

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 923d
  SEC Form 4 filed by Bitetti Teresa Marie

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 923d
  SEC Form 4 filed by Bender Jeremy

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1047d
  SEC Form 4 filed by Preston Heather

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1047d
  SEC Form 4 filed by Lee Philina

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1047d
  SEC Form 4 filed by Khuong Chau Quang

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1047d
  SEC Form 4 filed by Gannon Steven

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1047d
  SEC Form 4 filed by Duncan Barbara Gayle

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1047d
  SEC Form 4 filed by Cagnoni Pablo J

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1047d
  SEC Form 4 filed by Bergstrom Donald A

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1203d
  SEC Form 4 filed by Valliant John

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1203d
  SEC Form 4 filed by Rawat Mohit

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1203d
  SEC Form 4 filed by Leamon Christopher P

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1203d
  SEC Form 4 filed by Crowley John J

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1203d
  SEC Form 4 filed by Burak Eric

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1259d
  SEC Form 4: Khuong Chau Quang was granted 42,093 shares

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1266d
  SEC Form 4 filed by Bobilev Dmitri

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1354d
  SEC Form 4: Gannon Steven bought $90,132 worth of shares (44,400 units at $2.03), increasing direct ownership by 370% to 56,400 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1404d
  SEC Form 4 filed by Preston Heather

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1404d
  SEC Form 4 filed by Lee Philina

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1404d
  SEC Form 4 filed by Khuong Chau Quang

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1404d
  SEC Form 4 filed by Gannon Steven

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1404d
  SEC Form 4 filed by Duncan Barbara Gayle

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1404d
  SEC Form 4 filed by Cagnoni Pablo J

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1404d
  SEC Form 4 filed by Bergstrom Donald A

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1460d
  SEC Form 4: Valliant John sold $52,511 worth of shares (8,694 units at $6.04) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 318,147 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1465d
  SEC Form 4: Valliant John sold $7,751 worth of shares (1,289 units at $6.01) as part of a pre-agreed trading plan, decreasing direct ownership by 0.39% to 326,841 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1474d
  SEC Form 4: Valliant John sold $225,654 worth of shares (32,849 units at $6.87) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 328,130 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1479d
  SEC Form 4: Valliant John sold $16,457 worth of shares (2,181 units at $7.55) as part of a pre-agreed trading plan, decreasing direct ownership by 0.60% to 360,979 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1482d
  SEC Form 4: Valliant John sold $29,324 worth of shares (3,800 units at $7.72) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 363,160 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1486d
  SEC Form 4: Valliant John sold $2,256 worth of shares (300 units at $7.52) as part of a pre-agreed trading plan, decreasing direct ownership by 0.08% to 366,960 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1489d
  SEC Form 4: Valliant John sold $77,694 worth of shares (10,300 units at $7.54) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 367,260 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1494d
  SEC Form 4: Valliant John sold $36,092 worth of shares (4,800 units at $7.52) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 377,560 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1497d
  SEC Form 4: Valliant John sold $27,126 worth of shares (3,604 units at $7.53) as part of a pre-agreed trading plan, decreasing direct ownership by 0.93% to 382,360 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1502d
  SEC Form 4: Valliant John sold $10,459 worth of shares (1,500 units at $6.97) as part of a pre-agreed trading plan, decreasing direct ownership by 0.39% to 385,964 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1504d
  SEC Form 4: Valliant John sold $19,832 worth of shares (2,822 units at $7.03) as part of a pre-agreed trading plan, decreasing direct ownership by 0.72% to 387,464 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1510d
  SEC Form 4: Valliant John sold $103,945 worth of shares (14,504 units at $7.17) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 390,286 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1515d
  SEC Form 4: Valliant John sold $205,201 worth of shares (27,593 units at $7.44) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 404,790 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1518d
  SEC Form 4: Valliant John sold $103,176 worth of shares (13,752 units at $7.50) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 432,383 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)
• 1523d
  SEC Form 4: Valliant John sold $298,434 worth of shares (38,297 units at $7.79) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 446,135 units

  4 - Fusion Pharmaceuticals Inc. (0001805890) (Issuer)

Other FUSN categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends